QIB Extra

QIB Extra Ltd provides a high quality strategic and applied research service to small and medium-sized companies as well as large multi-nationals in the food, diet and health and allied sectors. It is a wholly-owned subsidiary of the Quadram Institute BioScience (QIB) with its headquarters on the Norwich Research Park. With expertise in microbiology, authenticity and rheological investigations into the structure of foods, QIB Extra Ltd will undertake bespoke applied food research, trouble-shooting and specialist analysis making QIB's expertise available and affordable to all companies. We can also provide access to food experts on a consultancy basis. We have our own laboratories, a dedicated management team and staff but can also call on the full range of expertise and resources of the Quadram Institute. We are able to put together multidisciplinary teams quickly which can be enhanced by the expertise and capabilities of our carefully selected partners on the Norwich Research Park and further afield. We will undertake short-term applied food research, trouble-shooting and specialist analysis making IFR's expertise available and affordable to all companies. We can also provide access to food experts on a consultancy basis.

International Pheromone Systems Ltd

International Pheromone Systems Ltd. (IPS) is a customer-orientated company with over 35 years of experience in developing, producing and supplying high-quality insect pheromones and trapping systems to a growing international customer base. We specialise in manufacturing pheromones, traps and lures used to compliment and promote sustainable integrated pest management (IPM) in predominantly agriculture, horticulture, storage, urban and forestry settings. Our goal is to promote a more effective, economical and sustainable approach to pest management by incorporating sound IPM principles and science with the pheromones and trapping systems we produce. - Over 30 years of industry experience in insect pheromones and their trapping systems. - Pioneers in the manufacturing of pheromone and traps. - 150+ pest species pheromones available - Pheromones are fresh and made to order. - UK manufactured products. - Flexible and innovative approach to developing new products. - World-wide distribution network.

Neem Biotech Limited

From modest beginnings 20 years ago as a niche contract research business, Neem Biotech has come of age. What started out with R&D around a neem tree and its medicinal purposes has now grown into a drug discovery company, focused on combating antibacterial resistance. Today, we discover novel assets and de-risk them by taking them up to the pre-clinical development stage before spinning them out into subsidiaries focused on distinct therapeutic applications. To fully leverage our unique position in antimicrobial R&D, we are undertaking an exciting anti-virulence approach to discover novel small molecules by utilising our expertise in bacterial-host interactions and coupling this with the exciting approach of fragment screening to discover novel compound programs.

Alpha Masonry

XOStem, Inc

XOStem is on the leading edge of translational biochemistry, using our Stem Cell expertise to create the next generation treatment for Type 1 Diabetes and produce Engineered Exosomes. Our combination of commercially developed science, partnerships with key scientific institutions, and university validation, enables us to rapidly bring to market novel therapies to tangibly improve people's lives. More applications utilizing our Stem Cell technology will follow. Our engineered exosome science is bringing to market the next generation of exosomes for regenerative skin care, joint care, and other therapies. Our research, technology and assays encompass the best methods for exosome isolation, purity, and characterization. More importantly our science leads the new frontier of engineered exosomes that carry well-defined payloads for more successful outcomes. Our bioscience device will contain insulin producing cells similar to islets found in a healthy pancreas. Our unique encapsulation technology protects our cells from the autoimmune attack that killed the islets in the patient's pancreas. Our device eliminates the pricking, needles, sensors and ports used by traditional insulin injection. Existing therapies for type 1 diabetes patients inject insulin using manual or automated methods, attempting to emulate pancreatic islet production of insulin. While better methods for monitoring and injection have been attempted, many drawbacks exist, and none control blood sugar levels to the tight level of natural islets. More importantly, the micro encapsulated islets combined with our macro device will control blood sugar levels to the same levels of a normal pancreas, minimizing the likelihood of the dreaded diabetes complications. Our team has decades of experience refining our technology in the laboratory, we are now moving to alleviate type 1 diabetes in companion animals (Dogs and Cats), once our process has significant successful data, we will then move to humans.